Vered Bronner
Impact in
-
- Ubiquitin and proteasome pathways
- Mitochondrial Function and Pathology
- Advanced Biosensing Techniques and Applications
- ATP Synthase and ATPases Research
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- Ubiquitin and proteasome pathways 3
- Protein purification and stability 2
- Glycosylation and Glycoproteins Research 2
- Oncology 3
- Co-authors
- Tsafrir Bravman (6 shared papers)Michael H. Glickman (2 shared papers)David Fushman (2 shared papers)Rina Rosenzweig (2 shared papers)Daoning Zhang (2 shared papers)David G. Myszka (1 shared paper)Giuseppe A. Papalia (1 shared paper)Varda Shoshan‐Barmatz (1 shared paper)
- Journals
- Analytical Biochemistry (3 papers)Molecular Microbiology (2 papers)Molecular Cancer Therapeutics (1 paper)Cellular and Molecular Bioengineering (1 paper)Oncogene (1 paper)
- Partner nations
- IsraelUnited StatesNetherlands
In The Last Decade
Vered Bronner
11 papers receiving 704 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 563
- Cancer Research 90
- Oncology 141
- Cell Biology 91
- Radiology, Nuclear Medicine and Imaging 98
Countries citing papers authored by Vered Bronner
This map shows the geographic impact of Vered Bronner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vered Bronner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vered Bronner more than expected).
Fields of papers citing papers by Vered Bronner
This network shows the impact of papers produced by Vered Bronner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vered Bronner. The network helps show where Vered Bronner may publish in the future.
Co-authors
The 25 scholars most cited alongside Vered Bronner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 176 | |
| 2 | 2006 | 144 | |
| 3 | 2009 | 99 | |
| 4 | 2012 | 94 | |
| 5 | 2010 | 53 | |
| 6 | 2008 | 44 | |
| 7 | 2008 | 43 | |
| 8 | 2021 | 37 | |
| 9 | 2010 | 16 | |
| 10 | 2008 | 9 | |
| 11 | 2010 | 2 |
About Vered Bronner
Vered Bronner is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Biomedical Engineering, having authored 11 papers that have together received 717 indexed citations. Recurring topics across this work include Viral Infectious Diseases and Gene Expression in Insects (3 papers), Ubiquitin and proteasome pathways (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Protein purification and stability (2 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Nanowire Synthesis and Applications (1 paper) and Advanced Proteomics Techniques and Applications (1 paper). The work is most often cited by research in Molecular Biology (563 citations), Cancer Research (90 citations), Oncology (141 citations), Cell Biology (91 citations) and Radiology, Nuclear Medicine and Imaging (98 citations). Vered Bronner has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Tsafrir Bravman, Michael H. Glickman, David Fushman, Rina Rosenzweig, Daoning Zhang, David G. Myszka, Giuseppe A. Papalia, Varda Shoshan‐Barmatz, Adrian Israelson and Zeev Zaslavsky. Their work appears in journals such as Analytical Biochemistry, Molecular Microbiology, Molecular Cancer Therapeutics, Cellular and Molecular Bioengineering and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.